Glean Kerron, Chawla Mehul, Mahabir-Glean Ria, Ganga Stefan, Ramsaroop Kishan
General Internal Medicine, University Hospitals Plymouth NHS Trust, Plymouth, GBR.
Cardiology, South West Regional Health Authority, San Fernando, TTO.
Cureus. 2024 Oct 15;16(10):e71577. doi: 10.7759/cureus.71577. eCollection 2024 Oct.
Weight loss is well known to improve cardiovascular health. Its benefits are widespread including reducing cardiovascular morbidity and mortality, improving clinical outcomes in diabetic and hypertensive patients and mobility in osteoarthritis patients. A well-planned weight-loss program has many benefits; however, one should be careful when trying to lose weight too rapidly, especially when that involves radical weight-loss products or regimes. We present a possible case of supraventricular tachycardia (SVT) associated with a ketone-based weight-loss product in an overweight but otherwise healthy 44-year-old Indo-Caribbean male. The patient presented to the Emergency Department with palpitations and an ECG demonstrating SVT at 221 beats per minute (BPM). He was converted to sinus rhythm with adenosine, started on beta-blockers, and treated with intravenous fluids, which led to a positive outcome. This patient had no major risk factors for SVT development other than starting an intense weight-loss regime with a ketone-based weight-loss product a few days before the development of the tachyarrhythmia. Our aim is to explore the possibility of this ketone-based weight product contributing to the development of SVT in our patient and to discuss the implications of these products on cardiac health.
众所周知，体重减轻有助于改善心血管健康。其益处广泛，包括降低心血管发病率和死亡率、改善糖尿病和高血压患者的临床结局以及骨关节炎患者的活动能力。精心规划的减肥计划有诸多益处；然而，在试图过快减肥时应谨慎，尤其是当涉及激进的减肥产品或方法时。我们报告一例可能与酮类减肥产品相关的室上性心动过速（SVT）病例，患者为一名44岁超重但其他方面健康的印度加勒比男性。该患者因心悸就诊于急诊科，心电图显示SVT，心率为每分钟221次（BPM）。他通过腺苷转为窦性心律，开始使用β受体阻滞剂，并接受静脉补液治疗，最终取得了良好的效果。除了在心律失常发生前几天开始使用基于酮的减肥产品进行强化减肥计划外，该患者没有其他导致SVT发生的主要危险因素。我们的目的是探讨这种基于酮的减肥产品导致我们患者发生SVT的可能性，并讨论这些产品对心脏健康的影响。
